Vespa invests in Random42

The fresh capital will fund the company's further expansion in its existing international markets, including North America and Japan.

Vespa most recently invested in video games developer Catalis in May 2014. Another portfolio company, Imagesound, also undertook a refinancing two months later, with Investec providing £5.5m of senior debt facilities.

Company
Founded in 1991 and headquartered in London, Random42 develops 3D medical animation software for the pharmaceutical and biotech sectors. Its clients include AstraZeneca, Bayer, GlaxoSmithKline, Pfizer and Novartis.

People
Nigel Hammond, a partner in Vespa's London office, led the deal alongside Tom Chaloner. Ben Ramsbottom is CEO of Random42.

Advisers
Equity – Plural Strategy Group (Commercial due diligence).
Company – Ingenious Corporate Finance, David Brooks, Graham Smith (Corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Technology
• United Kingdom
• Vespa Capital